The medical technology group Carl Zeiss Meditec defied the rather moderate start to the new fiscal year on Friday: The shares quickly shook off their pre-market weakness with the start of trading and. | February 10, 2023
Already positive, the research from UBS and its analyst Graham Doyle still consider the stock as a Buy opportunity. The target price continues to be set at EUR 156. | January 25, 2023
EQS-News: Carl Zeiss Meditec AG / Key word: Annual Results/Annual Report
Carl Zeiss Meditec remains on growth course in fiscal year 2021/22
09.12.2022 / 07:00 CET/CEST
The. | December 9, 2022
In a research note published by Beatrice Allen, Berenberg gives a Neutral rating to the stock. The target price is lowered from EUR 180 to EUR 135. | September 13, 2022